Karyopharm Therapeutics reported $37.65M in Selling and Administration Expenses for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.79B 7M
Abbvie ABBV:US $ 3.07B 228M
Acceleron Pharma XLRN:US $ 31.06M 4.85M
Amgen AMGN:US $ 1.25B 519M
Astrazeneca AZN:US 2.57B 76M
AstraZeneca AZN:LN 2.57B 76M
Biocryst Pharmaceuticals BCRX:US $ 22.11M 1.13M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Eli Lilly And LLY:US $ 1.58B 22.1M
Enanta Pharmaceuticals ENTA:US $ 8.33M 949K
Epizyme EPZM:US $ 36.41M 1.39M
GlaxoSmithKline GSK:LN 2.5B 183M
Johnson & Johnson JNJ:US $ 6.07B 641M
Karyopharm Therapeutics KPTI:US $ 37.65M 3.72M
Macrogenics MGNX:US $ 15.23M 198K
Merk MRK:US $ 2.25B 376M
Mirati Therapeutics MRTX:US $ 28.35M 3.01M
Nektar Therapeutics NKTR:US $ 31.68M 4.54M
Novartis NVS:US 3.71B 190M
Novartis NOVN:VX 3.52B 388M
Pfizer PFE:US $ 2.79B 134M
Regeneron Pharmaceuticals REGN:US $ 405.6M 102.1M
Sangamo Biosciences SGMO:US $ 16.15M 726K
Takeda 4502:JP 219.84B 14.55B
Tg Therapeutics TGTX:US $ 34.02M 7.26M
Ultragenyx Pharmaceutical RARE:US $ 53.41M 152K
Xencor XNCR:US $ 8.23M 623K
YTE INCY:US $ 153.79M 13.19M